Kangji Medical Holdings Limited (HKG:9997)
9.05
-0.02 (-0.22%)
Nov 6, 2025, 3:44 PM HKT
Kangji Medical Holdings Revenue
Kangji Medical Holdings had revenue of 496.56M CNY in the half year ending June 30, 2025, with 23.03% growth. This brings the company's revenue in the last twelve months to 1.05B, up 6.72% year-over-year. In the year 2024, Kangji Medical Holdings had annual revenue of 1.01B with 8.92% growth.
Revenue (ttm)
1.05B CNY
Revenue Growth
+6.72%
P/S Ratio
9.55
Revenue / Employee
1.04M CNY
Employees
1,007
Market Cap
10.96B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.01B | 82.59M | 8.92% |
| Dec 31, 2023 | 926.02M | 139.66M | 17.76% |
| Dec 31, 2022 | 786.37M | 96.10M | 13.92% |
| Dec 31, 2021 | 690.26M | 178.77M | 34.95% |
| Dec 31, 2020 | 511.49M | 8.02M | 1.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |